Hampton Creek Press (print and distribution provided by Simon & Schuster) Announces Behind a Closed Door, the Latest Novel by Writer J.D. Barker
17 avr. 2024 13h51 HE
|
Hampton Creek Press
The long-awaited thriller from New York Times bestselling author J.D. Barker is available for preorder now and will be released on May 13, 2024.
Upwork Premieres New Partner Program to Expand Ecosystem of Companies Transforming How We Work
17 avr. 2024 09h00 HE
|
Upwork Inc.
New Upwork Partners program helps companies better serve the needs of their customers by tapping highly skilled professionals on Upwork
aTyr Pharma to Participate in April Investor Conferences
01 avr. 2024 08h00 HE
|
aTyr Pharma, Inc.
aTyr Pharma to Participate in April Investor Conferences
CareerCircle Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2024
19 mars 2024 08h01 HE
|
CareerCircle
CareerCircle Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2024
NACCE Acquires SkillPointe to Connect Students to Community College Programs for High-Earning Careers
14 févr. 2024 12h00 HE
|
National Association For Community College Entrepreneurship
CARY, NC USA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The National Association for Community College Entrepreneurship (NACCE) announced the acquisition of the SkillPointe technology platform at the Cary...
As Employers Prioritize Skills and Retention, Plum Experiences Increasing Growth
05 févr. 2024 07h00 HE
|
Plum
Plum reports 230 percent growth over the last two years as employers prioritize skills and retention.
Fuel50 & Degreed Partner to Launch Learn+, a Connected Experience Driving Purposeful Growth
01 févr. 2024 10h30 HE
|
Fuel50
Fuel50 & Degreed Partner to Launch Learn+, a Connected Experience Driving Purposeful Growth
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
29 janv. 2024 08h00 HE
|
aTyr Pharma, Inc.
aTyr Pharma to present posters on the importance of Neuropilin-2 in immune regulation at the Keystone Symposia on Myeloid Cell Diversity.
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
13 nov. 2023 08h00 HE
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
09 nov. 2023 16h00 HE
|
aTyr Pharma, Inc.
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated...